LivingGLP1
Study S002167

Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes

Registration

Registration
NCT00572689
Study type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Phase
PHASE4
Masking
NONE
Status
WITHDRAWN
Enrollment
0
Start
2013-08
Primary completion
2015-08
Lead sponsor
Georgetown University
Conditions
Gestational Diabetes
Interventions
DRUG:Exenatide; GENETIC:Buccal/blood Sample Collection
Results posted
FALSE
Secondary identifiers
OTHER:202-801-2636

Registered primary outcomes

  • glycemic control through insulin, glucose, c-peptide and glucagon assays [duing testing days]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.